Legal entity
Last mentioned: Mar 20, 2026
Entity pulse
Coverage balance Balanced directional read. Positive and negative coverage are within 0 percentage points.
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
Every one of those 4 sits in a single category, regulation. Source depth averages 8.3 original sources per story, versus 3.4 across the same-window beat baseline. Of the tracked stories, 1 of 4 also mention #WeCount report, the most common co-covered peer. Across a 138-day span, the pace is roughly 0.2 stories per week. The 6.8 average consequence score is above the beat benchmark of 6.5 in the same window. We currently track 4 Legal stories that mention Food and Drug Administration (FDA), published between February 26, 2026 and July 13, 2026.
Computed from the 4 stories linked to this entity, with beat comparisons drawn from all 1442 Legal stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Food and Drug Administration (FDA). Shared-story counts are live from our verified record — not editorial picks.
ALJ Hearing on Marijuana Rescheduling
A seven-day administrative hearing is held in Arlington, Virginia, debating whether marijuana has a 'currently accepted medical use' without MMJ's testimony or evidence.
DEA Excludes MMJ from Rescheduling Hearing
The DEA denies MMJ International Holdings' request to participate in the upcoming administrative hearing, asserting that its evidence raises only questions of law.
Federal Appeals Court Bans Mailing Mifepristone
A federal appeals court made it illegal to mail mifepristone, a key medication abortion pill, threatening telehealth access.
Supreme Court Issues Stay on Mifepristone Ban
The Supreme Court stayed the appeals court ruling, allowing mailing to continue while the legal challenge proceeds.
Legal Challenges
Expected filing of lawsuits by environmental groups to block the relaxation of standards.
EPA Rollback Proposal
The EPA announces moves to weaken the previously established pollution limits.
Industry Petitions
Medical tech groups and the FDA raise alarms about potential device shortages due to facility closures.
Strict Standards Finalized
EPA issues a rule requiring a 90% reduction in EtO emissions from sterilization plants.
Supreme Court Overturns Roe v. Wade in Dobbs Decision
The landmark ruling eliminated the constitutional right to abortion, allowing states to enact bans.
MMJ International Holdings alleges the DEA violated administrative law by excluding it from marijuana rescheduling hearings, despite spending $10 million on FDA-pathway development. The exclusion raises due process and APA concerns that could imperil the final rule.
Source: saltlakecitysun.com · memphissun.com
Despite state bans, U.S. abortions nearly doubled, fueled by telehealth pill delivery across state lines. This exposes legal tensions between state authority, FDA preemption, and 19th-century obscenity statutes.
The Environmental Protection Agency has proposed a relaxation of pollution standards for chemicals used in medical equipment sterilization, specifically targeting Ethylene Oxide (EtO). This move attempts to balance carcinogenic health risks against the critical need to maintain the national medical device supply chain.
Source: winnipegfreepress.com · kten.com
The U.S. Food and Drug Administration is implementing a performance-based bonus structure to reward staffers who complete drug reviews ahead of schedule. This initiative aims to accelerate the therapeutic pipeline but has sparked immediate debate over the potential impact on safety standards and regulatory rigor.
Source: sbsun.com · timesargus.com
Food and Drug Administration (FDA) is linked from 4 stories on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
